<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In May 2005 at the 8th International Symposium on <z:hpo ids='HP_0002863'>Myelodysplastic Syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), a consensus meeting was held on <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25) </plain></SENT>
<SENT sid="1" pm="."><plain>The recommendations of the 2005 consensus meeting were discussed in the context of currently available evidence at the 9th International Symposium on <z:hpo ids='HP_0002863'>Myelodysplastic Syndromes</z:hpo> in Florence Italy, May 2007 </plain></SENT>
<SENT sid="2" pm="."><plain>The recommendations of the consensus working group are presented here </plain></SENT>
<SENT sid="3" pm="."><plain>The recommendations are a continued refinement of the outcome of the 2005 consensus meeting and the ground-breaking work of others in this area (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25; Gattermann, Int J Hematol 2008;88:24-29; Alessandrino et al., Haematologica 2002;87:1286-1306; <z:chebi fb="0" ids="29308,30347">NCCN</z:chebi> practice guidelines: <z:hpo ids='HP_0002863'>Myelodysplastic Syndromes</z:hpo>, version 2.2008) </plain></SENT>
</text></document>